Reported Standalone quarterly numbers for Suven Life Sciences are:
Net Sales at Rs 1.47 crore in March 2025 down 38.5% from Rs. 2.39 crore in March 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 15.07 crore in March 2025 down 382.41% from Rs. 3.12 crore in March 2024.
EBITDA stands negative at Rs. 13.72 crore in March 2025 down 429.73% from Rs. 2.59 crore in March 2024.
Suven Life Sci shares closed at 153.07 on May 09, 2025 (NSE) and has given 20.65% returns over the last 6 months and 52.38% over the last 12 months.
Story continues below Advertisement
| Suven Life Sciences | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'25 | Dec'24 | Mar'24 | | Net Sales/Income from operations | 1.47 | 1.61 | 2.39 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 1.47 | 1.61 | 2.39 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | -- | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 6.07 | 4.87 | 3.46 | | Depreciation | 1.35 | 1.53 | 1.51 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | 8.49 | 8.26 | 4.18 | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 1.83 | 1.78 | 1.61 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -16.26 | -14.83 | -8.38 | | Other Income | 1.19 | 1.57 | 4.28 | | P/L Before Int., Excpt. Items & Tax | -15.07 | -13.26 | -4.10 | | Interest | -- | 0.01 | 0.03 | | P/L Before Exceptional Items & Tax | -15.07 | -13.27 | -4.13 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -15.07 | -13.27 | -4.13 | | Tax | -- | -- | -1.00 | | P/L After Tax from Ordinary Activities | -15.07 | -13.27 | -3.12 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -15.07 | -13.27 | -3.12 | | Equity Share Capital | 21.81 | 21.81 | 21.81 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.69 | -0.61 | -0.14 | | Diluted EPS | -0.69 | -0.61 | -0.14 | | EPS After Extra Ordinary | | Basic EPS | -0.69 | -0.61 | -0.14 | | Diluted EPS | -0.69 | -0.61 | -0.14 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
